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Abbreviations:  31 
Cul3, Cullin 3; FHHt, familial hyperkalemic hypertension; CSN, COP9 signalosome; WNK, with-no-lysine 32 
kinase; NCC, Na-Cl cotransporter; DCT, distal convoluted tubule; SPAK, serine/threonine protein kinase 39; 33 
OSR1, oxidative stress-response 1; CRL, cullin-RING ligase; KLHL3, kelch-like 3; NEDD8, neuronal 34 
precursor cell expressed developmentally down-regulated protein 8; JAB1, jun activation domain-binding 35 
protein-1; 4HB, 4-helix bundle; WT, wild type; BTB, bric-a-brac, tramtrack, broad-complex; CAND1, cullin-36 
associated and NEDD8-dissociated protein 1; Keap1, kelch-like ECH-associated protein-1; Nrf2, nuclear factor 37 
erythroid 2-related factor 2; 3-MA, 3-methyladenine. 38 
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Abstract 40 
 Familial hyperkalemic hypertension is caused by mutations in WNK kinases, or in proteins that mediate 41 
their degradation, KLHL3 and cullin 3 (Cul3). While the mechanisms by which WNK and KLHL3 mutations 42 
cause the disease are now clear, the effects of the disease-causing Cul3Δ403-459 mutation remain controversial. 43 
Possible mechanisms including hyperneddylation, altered ubiquitin ligase activity, decreased association with 44 
the COP9 signalosome (CSN), and increased association with and degradation of KLHL3 have all been 45 
postulated. Here, we systematically evaluated the effects of Cul3Δ403-459 using cultured kidney cells. We first 46 
identified that the catalytically active CSN subunit JAB1 does not associate with the deleted Cul3 4HB domain, 47 
but instead with the adjacent α/β1 domain, suggesting that altered protein folding underlie the impaired binding. 48 
Inhibition of deneddylation, with JAB1 siRNA, increased Cul3 neddylation, and decreased KLHL3 abundance, 49 
similar to the Cul3 mutant. We next determined that KLHL3 degradation has both ubiquitin ligase-dependent 50 
and -independent components. Proteasomal KLHL3 degradation was enhanced by Cul3Δ403-459; however, 51 
autophagic degradation was also upregulated by this Cul3 mutant. Finally, to evaluate whether deficient 52 
substrate adaptor was responsible for the disease, we restored KLHL3 to WT-Cul3 levels. In the absence of 53 
WT-Cul3, WNK4 was not degraded, demonstrating that Cul3Δ403-459 itself cannot degrade WNK4; 54 
conversely, when WT-Cul3 was present, as in diseased humans, WNK4 degradation was restored. In 55 
conclusion, deletion of exon 9 from Cul3 generates a protein that is itself ubiquitin ligase-defective, but also 56 
capable of enhanced autophagocytic KLHL3 degradation, thereby exerting dominant-negative effects on the 57 
WT-allele. 58 
 59 
Keywords: Cullin-RING ubiquitin ligase, Neddylation, Deneddylation, JAB1 60 
 61 
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Introduction 64 
 With-no-lysine (WNK) kinases control blood pressure and potassium homeostasis, predominantly by 65 
regulating membrane expression and activity of the thiazide-sensitive Na-Cl cotransporter (NCC) in the distal 66 
convoluted tubule (DCT). These kinases signal via serine/threonine protein kinase 39 (SPAK; STK39) and 67 
oxidative stress-response 1 (OxSR1 or OSR1; OXSR1), which directly phosphorylate and activate the transport 68 
protein (19, 30). The human Mendelian disease Familial Hyperkalemic Hypertension (FHHt, also called 69 
pseudohypoaldosteronism type 2 or Gordon syndrome) results from activation of this signaling pathway in the 70 
distal nephron (21). FHHt patients exhibit hyperkalemia, metabolic acidosis, and hypertension, symptoms that 71 
largely disappear during treatment with thiazide diuretics (13). FHHt can be caused by mutations in WNK1 or 72 
WNK4 (32), or in the cullin-RING ligase (CRL) proteins cullin 3 (Cul3) (4) and kelch-like 3 (KLHL3) (28). 73 
Cul3 is part of an E3 ubiquitin ligase complex that regulates protein degradation. CRLs do not degrade proteins 74 
directly, but instead attach strings of ubiquitin moieties to a protein, thereby targeting it for degradation, 75 
typically within the proteasome. Cullin acts as a scaffold protein for the other CRL subunits. It is now clear that 76 
WNK kinases are targets for CRLs. The substrate adaptor KLHL3, binds both WNK kinases and Cul3, bringing 77 
the WNK into proximity to the catalytic region of the CRL, thereby permitting ubiquitylation (18, 25). The 78 
WNK4 or KLHL3 mutations that cause disease, do so by disrupting these binding reactions, permitting WNKs 79 
to accumulate (31). The Cul3 mutations that cause FHHt, however, do not decrease substrate adaptor binding 80 
(27, 31); although mouse models indicate that WNKs are not degraded normally (24), the precise mechanisms 81 
involved remain controversial.  82 
An important feature of CRL activity is the attachment of NEDD8 (neuronal precursor cell expressed 83 
developmentally down-regulated protein 8) through a process called neddylation. NEDD8 attachment is 84 
required to activate CRLs by increasing the flexibility of the cullin-ring structure, allowing the transfer of 85 
ubiquitin from the RING protein to the target substrate (3, 20, 23). The reverse process, deneddylation, is 86 
facilitated by the multi-subunit COP9 signalosome (CSN) complex. The CSN interacts with CRLs and removes 87 
NEDD8 through its catalytically-active CSN5 subunit, also known as JAB1 (jun activation domain-binding 88 
protein-1) (6). Although a simple model originally suggested that neddylated Cul3 is active, whereas 89 
unneddylated Cul3 is inactive, inhibition of CSN paradoxically increases, rather than decreases, the abundance 90 
of substrate proteins in vivo (22). It appears instead that, while neddylation of cullins is indeed essential to 91 
activate them, it also makes them unstable and prone to degradation (35). Thus, the effects of neddylation on 92 
cullin activity and abundance are complex. 93 
All known FHHt-causing Cul3 mutations cause deletion of exon 9, resulting in a mutant protein that 94 
lacks 57 amino acid residues (Cul3Δ403-459) (4). Previous work by our group (14), and confirmed by others 95 
(24), showed that Cul3Δ403-459, expressed in cells, is hyperneddylated, compared with wild type (WT), 96 
suggesting either that it is more susceptible to neddylation or that it is resistant to deneddylation. Schumacher et 97 
al. (24) confirmed that Cul3Δ403-459 had impaired deneddylation and compromised CSN binding, suggesting 98 
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that the deleted segment was responsible. Exon 9 of Cul3 encodes the 4-helix bundle (4HB) domain. Min et al. 99 
(15) demonstrated that the CSN binding site for the closely related cullin 1 protein was located within the 4HB 100 
and α/β1 domains. However, the CSN binding site for Cul3 has yet to be determined.  101 
Cul3Δ403-459 has an increased association with bric-a-brac, tramtrack, broad-complex (BTB)-Kelch 102 
substrate adaptor proteins, including KLHL3 (10, 14, 24). The FHHt Cul3 mutant strongly ubiquitylated 103 
KLHL3 (14, 24) leading to decreased abundance, in vitro (14). However, administration of the non-specific 104 
neddylation inhibitor, MLN4924, which prevents NEDD8 conjugation and presumably inactivates CRLs, only 105 
partially normalized KLHL3 abundance. Additionally, the enhanced interaction of KLHL3 with Cul3Δ403-459 106 
remained in the absence of neddylation. The results indicate that Cul3Δ403-459 may have neddylation-107 
dependent and neddylation-independent effects. Here, we examined the mechanisms and consequences of 108 
Cul3Δ403-459 hyperneddylation, and identified novel ligase dependent, and ligase independent mechanisms for 109 
the human disease. 110 
 111 
Materials and Methods  112 
Antibodies 113 
 Antibodies used are described in Table 1. 114 
 115 
Cell culture, plasmids, and transfections 116 
For cell culture experiments HEK293 cells were used unless otherwise stated. CRISPR-Cas9-edited 117 
Cul3 knockdown HEK293T cells (HEK293T
Cul3-KO
) were previously reported (10). Cells were maintained in 118 
DMEM supplemented with 10% FBS, 25 mM HEPES, 100 units/ml penicillin, 100 µg/ml streptomycin. Cells 119 
were transiently transfected using Lipofectamine 2000 (Ambion, Foster City, CA, USA; Invitrogen). Cul3 120 
constructs were made by amplifying FLAG-Cul3 WT DNA using Phusion Hot Start II DNA Polymerase 121 
(Thermo Fisher Scientific, Boston, MA, USA) with the appropriate primers, purified with the PureLink PCR 122 
Purification Kit (Invitrogen) and properly digested. The products were then extracted using the UltraClean 123 
GelSpin DNA Extraction Kit (MoBio Laboratories, Inc., Carlsbad, CA, USA) and ligated into N-terminal GST 124 
tag mammalian plasmid, pSF-CMV-Puro-NH2-GST (Oxford Genetics, Oxford, UK), with T4 DNA Ligase 125 
(New England BioLabs, Ipswich, MA, USA). Ligated constructs were transformed using DH5α competent cells 126 
(Thermo Fisher Scientific) and plasmid DNA was purified with either the QIAprep Spin Miniprep Kit or 127 
HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany). Sanger sequencing was performed for all constructs. 128 
For siRNA experiments, either 40 nM of COPS5 siRNA (Ambion) or control siRNA was transfected 129 
along with DNA plasmids. Cells were harvested at 36 h post-transfection. 130 
For cycloheximide chase experiments, cycloheximide was added 36 h after transfection at a 131 
concentration of 100 µg/ml and the cells were lysed at the time points indicated.  132 
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For MG132, chloroquine, 3-methyadenine, MLN4924, and tBHQ experiments, drug was added to cells 133 
18 h before harvesting at the concentrations given. 134 
For ubiquitin assay experiments, cells were co-transfected with HA-tagged ubiquitin DNA plasmid. 135 
Cells were lysed 48 h after transfection in cell lysis buffer containing 10 mM N-ethylmaleimide. 136 
Immunoprecipitation and Western blotting was carried out as below.   137 
  138 
Immunoprecipitation and Western blotting  139 
Transfected cells were harvested in 0.5% Triton X-100 in PBS cell lysis buffer containing enzyme 140 
inhibitors. For immunoprecipitation cell lysate was pre-cleared with protein A-sepharose beads for 1-2 hours. 141 
Cell lysate was then incubated with Glutathione Sepharose 4B medium (GE Healthcare, Piscataway, NJ, USA) 142 
for 2 h at room temperature, primary antibody and Protein A-Sepharose 4B medium (GE Healthcare) or anti-143 
FLAG Affinity Gel (Biotool, Houston, TX, USA) overnight at 4° C. Protein samples were separated by 144 
electrophoresis on 4-12% NuPAGE bis-tris polyacrylamide gels (Thermo Fisher Scientific) or 4-15% Criterion 145 
TGX stain-free gels (Bio-Rad Laboratories, Hercules, California, USA) and transferred to Immobilon-P PVDF 146 
membranes (EMD Millipore, Billerica, MA, USA). For all experimental conditions performed in triplicate, each 147 
well represents a unique transfection. Stain-free imaging was used as a total protein loading control, unless 148 
otherwise stated. Membranes were blocked with 5% milk in PBS for 1 h at room temperature before incubation 149 
with primary antibody in blocking buffer for 1 h at room temperature or overnight at 4° C. Appropriate HRP-150 
conjugated secondary antibody in blocking buffer was added to membranes for 1 h at room temperature. 151 
Membranes were developed using enhanced chemiluminescence, Western Lightning Plus–ECL (Perkin Elmer, 152 
Waltham, MA, USA), and proteins were visualized using PXi digital imaging system (Syngene, Frederick, MA, 153 
USA). 154 
 155 
Statistics 156 
Data are presented as individual values as well as mean ± SEM. Differences between two groups were 157 
determined using two-tailed unpaired Student’s t-test and differences between multiple groups were analyzed 158 
using one-way ANOVA followed by Tukey’s multiple comparisons test. A P value of less than 0.05 was 159 
considered significant. Statistical analysis was performed using GraphPad Prism 7 software (GraphPad 160 
Software, San Diego, CA, USA). 161 
 162 
Results 163 
CSN binds to Cul3 at the α/β1 domain. 164 
CRLs are activated by NEDD8 attachment, but for full functionality, they must also be deneddylated. 165 
The deneddylation of Cul3 appears to be disrupted in Cul3Δ403-459 FHHt, as the mutant protein is more highly 166 
neddylated than WT, at least when expressed in cultured cells (14, 24). Schumacher et al. reported that 167 
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Cul3Δ403-459 exhibits decreased interaction with JAB1 (24), suggesting that the deleted domain may include 168 
the CSN binding site. The crystal structure of CSN with the highly homologous cullin 1 (12) and cullin 4A (5), 169 
showed that the CSN2 subunit interacts directly with the C-terminal domain. Additionally, Min et al. (15) 170 
determined that the CSN binding site for cullin 1 (which is structurally similar to Cul3) was located specifically 171 
within the C-terminal domains 4HB and α/β1. Inspection of the Cul3 gene revealed that exon 9 (deleted in 172 
FHHt-causing Cul3 mutations) encodes the 4HB domain (see Figure 1A). To determine sites of CSN interaction 173 
with Cul3, we generated Cul3 deletion constructs (Figure 1A). We first confirmed that, compared with WT-174 
Cul3, there was minimal JAB1 precipitation by Cul3Δ403-459 (Figure 1B). Similarly, the Cul3 construct 175 
containing N-terminal residues 1-402, which lacks the 4HB domain and the adjacent α/β1 domain showed 176 
nominal precipitation of JAB1 (Figure 1C). Surprisingly, inclusion of the 4HB domain with the N-terminal 177 
region also showed low binding to JAB1 (Figure 1C, Cul3 1-459). These results indicate clearly that Cul3 178 
amino acids 403-459 (containing the 4HB domain) are not sufficient for binding to the CSN. This suggests that 179 
the Cul3Δ403-459 mutation does not impair Cul3-CSN binding directly, but rather disrupts protein folding 180 
within a site C-terminal to the 4HB domain; this suggestion is consistent with structural modeling of wild type 181 
and mutant Cul3 (24).  182 
To identify the specific binding site for the CSN and confirm that the 4HB does not bind JAB1 we 183 
developed individual Cul3 domain constructs for 4HB and α/β1. Additionally, we generated a construct 184 
containing both the 4HB and α/β1 domains (4HB:α/β1), an N-terminal construct containing cullin repeat 185 
sequences (R1:R2:R3) and a C-terminal construct containing domains WH-A, α/β2, and WH-B (WH-186 
A:α/β2:WH-B). JAB1 immunoprecipitated with the Cul3 construct containing both the 4HB and α/β1 domains 187 
and with α/β1 alone, but not with 4HB alone (Figure 1D). JAB1 was not precipitated with Cul3 constructs that 188 
lacked the α/β1 domain, R1:R2:R3 and WH-A:α/β2:WH-B. The results indicate that the first α/β domain of Cul3 189 
is the binding site for JAB1 and therefore the CSN.  190 
To verify that the α/β1 domain is the binding site for the CSN we developed a full-length Cul3 construct 191 
in which the α/β1 was deleted (Cul3Δ461-586). JAB1 was not precipitated with Cul3Δ461-586 (Figure 1E). As 192 
expected, Cul3Δ461-586 also showed enhanced neddylation compared to WT-Cul3. These results further 193 
confirm that the CSN binding site is contained within the α/β1 domain of Cul3.  194 
 195 
CSN inhibition enhances Cul3 neddylation and reduces KLHL3 and WNK4 abundance. 196 
Neddylation of cullins has paradoxical effects, with both neddylation and deneddylation being required 197 
for normal CRL function. Because Cul3Δ403-459 exhibits decreased interaction with JAB1 (24), we examined 198 
the effects of inhibiting JAB1 activity on Cul3 in HEK293 cells. Cells were transfected with siRNA to reduce 199 
endogenous JAB1. Western blotting for endogenous Cul3 exhibited a more neddylated Cul3 (as detected by an 200 
increase in the higher molecular weight Cul3 band) when JAB1 was reduced, compared to control (Figure 2). 201 
Similarly, probing the blot with an antibody against NEDD8 showed a greater abundance of neddylated Cul3 202 
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when JAB1 was knocked down, as the antibody recognized a product at the molecular weight of Cul3. The 203 
effects of JAB1 inhibition on the protein abundance of the Cul3 substrate adaptor KLHL3 and substrate WNK4 204 
were also determined. Abundance of overexpressed KLHL3 and WNK4 were lower, in cells transfected with 205 
JAB1 siRNA, compared to control siRNA, indicating that JAB1 knockdown and increased neddylation 206 
activates Cul3 in transfected cells.  207 
  208 
Cul3Δ403-459 causes decreased stability of KLHL3 209 
 We showed previously that KLHL3 protein abundance was lower when co-expressed with Cul3Δ403-210 
459 than with WT Cul3 in HEK293 cells (14), suggesting that degradation was more rapid in the presence of 211 
mutant Cul3. To test this, we measured the stability of KLHL3 using the cycloheximide chase assay. KLHL3 212 
abundance was significantly lower 24 hours after cycloheximide treatment when co-transfected with Cul3Δ403-213 
459 compared to WT Cul3, but the apparent degradation rates at other time points were not different (Figure 214 
3A). As KLHL3 co-transfected with WT Cul3 was stable at least 24 h after cycloheximide treatment (the long 215 
stability of KLHL3 has been previously published (17)), which can lead to anomalous results in cycloheximide 216 
chase experiments (37), we decided to examine a canonical CRL substrate, WNK4, using a similar approach. 217 
Similar to the Cul3-KLHL3 experiments, WNK4 was stable when cycloheximide was introduced in the absence 218 
of KLHL3; however, when co-transfected together with KLHL3, WNK4 abundance was strikingly reduced 219 
(Figure 3B). When we compared the effects of KLHL3 on WNK4 abundance with those of Cul3Δ403-459 on 220 
KLHL3 abundance, the results are remarkably similar (Figure 3C). In fact, when other groups have examined 221 
the effects of KLHL3 on WNK4 abundance, they also noted remarkably reduced WNK4 abundance in the 222 
presence of KLHL3 (31). Thus, although we cannot prove that the Cul3Δ403-459 and WT Cul3 have 223 
differential effects on KLHL3 synthesis, the current results, when coupled with those shown below suggest that 224 
KLHL3 is degraded more rapidly by the Cul3 mutant. 225 
 226 
Ligase-dependent and -independent effects of Cul3Δ403-459 on KLHL3 and WNK4.  227 
The Cul3Δ403-459 mutation has altered ubiquitin ligase activity as shown by increased ubiquitylation of 228 
KLHL3 and decreased ubiquitylation of WNK4 (14, 24). Yet, Cul3Δ403-459 also has ligase-independent 229 
effects, such as enhanced binding to BTB-Kelch adaptors and decreased binding to CSN subunits and cullin-230 
associated and NEDD8-dissociated protein 1 (CAND1) (10, 14, 24). To try to better understand the anomalous 231 
effects of the Cul3Δ403-459 protein we generated a neddylation-deficient Cul3Δ403-459 double mutant, 232 
Cul3Δ403-459 K712R. Neddylation is generally considered to be necessary to activate CRLs. The RING 233 
subunit utilizes specific E1 and E2 enzymes to covalently attach a NEDD8 protein to lysine 712 of Cul3 (33). 234 
Cul3Δ403-459 K712R includes a point mutation at the neddylation-site preventing NEDD8 attachment, and 235 
rendering the construct ligase-deficient. Immunoprecipitation of FLAG-tagged Cul3Δ403-459 K712R showed 236 
an almost complete loss of neddylation (Figure 4A), indicating that the vast majority of Cul3Δ403-459 237 
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neddylation occurs at the lysine 712 residue. Co-immunoprecipitation of the different Cul3 constructs and 238 
KLHL3 showed that similar to Cul3Δ403-459, Cul3Δ403-459 K712R bound to more KLHL3 protein compared 239 
to WT-Cul3 (Figure 4B), confirming that neddylation, and therefore ubiquitin ligase activity, is not required for 240 
increased protein binding. 241 
Ubiquitylation of the BTB-adaptor KLHL3 (Figure 4C) was greater in cells transfected with Cul3Δ403-242 
459, compared to WT-Cul3, as reported previously (14). As expected, this greater KLHL3 ubiquitylation was 243 
not apparent when the neddylation deficient Cul3Δ403-459 K712R was transfected. Yet the current results also 244 
suggest that ubiquitin ligase activity is not fully responsible for the anomalous Cul3Δ403-459 activity. In cells 245 
transfected with both KLHL3 and WNK4, the abundance of KLHL3 was lower, when Cul3Δ403-459 was 246 
present than with WT-Cul3, consistent with increased substrate adaptor ubiquitylation and degradation by the 247 
mutant protein (Figure 4D). Cul3Δ403-459 also led to more WNK4 abundance than did WT-Cul3 (Figure 4D), 248 
as we, and others, have reported previously. When the ligase-deficient Cul3Δ403-459 K712R construct was 249 
transfected, however, the effects on KLHL3 and WNK4 were reduced compared to Cul3Δ403-459 toward 250 
normal (WT-Cul3) levels, (Figure 4D). Unexpectedly, the effects of Cul3Δ403-459 on KLHL3 were not 251 
completely removed by the ligase-deficient Cul3Δ403-459 K712R double mutant, indicating that the effects of 252 
Cul3Δ403-459 is only partially dependent on ubiquitin ligase activity. 253 
  254 
Cul3Δ403-459-mediated KLHL3 degradation is both proteasome- and autophagy-dependent. 255 
As shown above, when ubiquitin ligase activity is lacking, as in the Cul3Δ403-459 K712R double 256 
mutant, there is less abundance of KLHL3, however, the amount of KLHL3 abundance retained by the 257 
construct (ligase-independent degradation) is still significant. Since the neddylation-deficient construct should 258 
block the ubiquitin-proteasome degradation pathway, the remaining Cul3Δ403-459-mediated KLHL3 259 
degradation could be autophagy-dependent. The proteasome is the canonical pathway for degrading 260 
ubiquitylated proteins, and it has been shown to contribute to WNK kinase degradation (14); yet there is also 261 
evidence that KLHL3 and WNK4 can be degraded via autophagy (16). To determine the pathways involved in 262 
Cul3Δ403-459-mediated KLHL3 degradation, we used the inhibitors MG132 and chloroquine. Proteasomal 263 
inhibition with 10 M MG132 had no effect on the control group, but partially suppressed Cul3Δ403-459-264 
mediated KLHL3 degradation (Figure 5). Inhibition of autophagy with 100 µM chloroquine, however, had a 265 
small but significant effect on the control group, indicating that KLHL3 is constitutively degraded via 266 
autophagy (Figure 6A). Incubation of Cul3Δ403-459 with chloroquine also resulted in a partial suppression of 267 
KLHL3 degradation. The percent change in KLHL3 protein abundance due to chloroquine administration was 268 
significantly different between control and Cul3Δ403-459 (Figure 6B), which indicates an increased autophagic 269 
degradation of KLHL3 mediated by the Cul3 mutant. To confirm these results, we treated cells with another 270 
autophagy blocker, 3-methylandenine (3-MA), an inhibitor of autophagosome formation (Figure 6C). The 271 
results closely resembled chloroquine administration further indicating autophagic KLHL3 degradation. 272 
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Treatment of the cells with both MG132 and chloroquine completely abolished Cul3Δ403-459-mediated 273 
KLHL3 degradation (Figure 6D). The data suggest that, under the conditions provided, KLHL3 is degraded by 274 
Cul3Δ403-459 through both the ubiquitin-proteasome pathway and the autophagy pathway. Thus, WT-Cul3 and 275 
Cul3Δ403-459 degrade WNK4 and KLHL3, respectively, via two different pathways. WNK4 is ubiquitylated 276 
and degraded through the proteasomal pathway. KLHL3 is degraded by both the proteasome and the autophagy 277 
pathway. 278 
  279 
Increasing KLHL3 expression normalizes Cul3Δ403-459-mediated inhibition of WNK4 degradation in the 280 
presence of WT-Cul3. 281 
 We suggested previously that the increased activity of Cul3Δ403-459 toward KLHL3 reduced the 282 
availability of KLHL3 to participate in degrading WNK kinases (14). Alternatively, others have suggested that 283 
the increased association of Cul3Δ403-459 with KLHL3 may sequester it, and accomplish the same effect. If 284 
the low level of KLHL3 contributes to the increase in WNK4 in Cul3Δ403-459 patients, then increasing the 285 
amount of KLHL3 should reduce WNK4. By increasing the amount KLHL3 DNA transfected into the cells we 286 
were able to increase KLHL3 protein abundance. In HEK293 cells that lack Cul3 (HEK293T
Cul3-KO
), an 287 
increase in KLHL3 protein levels caused only a slight reduction in WNK4 abundance (28%); WNK4 was still 288 
substantially higher than in cells transfected with WT-Cul3, even though KLHL3 protein abundance was similar 289 
(compare the first and last three lanes in Figure 7A). However, in HEK293 cells that contained endogenous 290 
WT-Cul3 (Figure 7B), increasing KLHL3 protein levels in cells transfected with Cul3Δ403-459 caused a 291 
striking reduction in WNK4 protein abundance (64%), to a value that was not significantly different from WT-292 
Cul3 transfected cells. The data show that Cul3Δ403-459 itself is unable to substantially degrade WNK4, even 293 
when KLHL3 is normalized, but when Cul3Δ403-459 and Cul3 are both present in cells, as they are in 294 
heterozygous humans, the addition of KLHL3 normalizes degradation of WNK4. This suggests that, in vitro, 295 
Cul3Δ403-459 degrades KLHL3, preventing WT-Cul3 from binding to WNK4. 296 
 297 
Cul3Δ403-459 exhibits a dominant effect in cells. 298 
 It has been suggested that Cul3Δ403-459 causes FHHt by inducing functional Cul3 haploinsufficiency, 299 
(10, 24). This suggestion derives from the observation that the abundance of Cul3Δ403-459 is very low in a 300 
knock-in mouse model of FHHt, and also that introducing a 1:1 molar ratio of WT-Cul3 to Cul3Δ403-459 did 301 
not inhibit ubiquitylation of WNK4 (24). Yet Uchida and colleagues noted that mice with functional Cul3 302 
haploinsufficiency do not exhibit signs of FHHt (2), and as noted above, Cul3Δ403-459 may either degrade 303 
and/or sequester KLHL3, thereby exerting a dominant negative effect (10, 14). To determine whether 304 
Cul3Δ403-459 has dominant effects in cells, we transfected both WT-Cul3 and Cul3Δ403-459 together at 305 
different ratios. In the presence of constant WT-Cul3, increasing Cul3Δ403-459 reduced KLHL3 abundance 306 
and increased WNK4 abundance (Figure 8), and increasing WT-Cul3 in the presence of Cul3Δ403-459 307 
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increased KLHL3 and decreased WNK4. Thus, Cul3Δ403-459 clearly exerts a dominant effect in cultured cells; 308 
this is consistent with the autosomal dominant inheritance of FHHt type 4. 309 
 310 
Cul3Δ403-459 does not affect Keap1 and cyclin E protein abundance  311 
 Because Cul3 can interact with and ubiquitinate multiple substrates through many different substrate 312 
adaptors, then it would be expected that the Cul3Δ403-459 mutant would affect other proteins besides KLHL3 313 
and WNK4. To better understand the effects of the Cul3Δ403-459 mutant, we examined three other proteins 314 
that interact with Cul3. The oxidative stress response protein, nuclear factor erythroid 2-related factor 2 (Nrf2), 315 
is another substrate of Cul3 and interacts through the BTB-Kelch substrate adaptor protein kelch-like ECH-316 
associated protein-1 (Keap1). Unlike KLHL3, Keap1 showed no change in protein abundance when cells were 317 
transfected with Cul3Δ403-459 or Cul3Δ403-459 K712R (Figure 9). Although Keap1 was unchanged, its 318 
substrate Nrf2 showed an increase in protein abundance in Cul3Δ403-459 transfected cells. The amplified Nrf2 319 
was also observed in cells transfected with Cul3Δ403-459 K712R. Cyclin E, which is a canonical Cul3 320 
substrate and is involved in cell cycle regulation, was unchanged when transfected with Cul3Δ403-459 or 321 
Cul3Δ403-459 K712R. The results demonstrate that the Cul3Δ403-459 mutant has differential effects on its 322 
substrates and substrate adaptors. 323 
 324 
Discussion 325 
Mutations in WNK1, WNK4, Cul3, and KLHL3 cause FHHt, predominantly by increasing NCC activity 326 
along the DCT, suggesting that these proteins comprise a single signaling pathway. The disease pathogenesis, in 327 
all cases, appears to result from an increase in WNK kinase abundance, either owing to enhanced transcription, 328 
or impaired degradation. While WNK4 and KLHL3 mutations impair the degradative arm of this pathway by 329 
disrupting the ability of WNK kinases to form complexes with KLHL3 and Cul3, the mechanisms involved in 330 
Cul3 disease have been more difficult to unravel (17, 18, 25, 28, 29, 31, 34). We reported previously that the 331 
FHHt-mutant Cul3 ubiquitylates and facilitates KLHL3 degradation more actively than does WT-Cul3, and 332 
suggested that the mutant exhibits dominant effects (14). The dominant nature of the Cul3Δ403-459 mutation 333 
was very recently confirmed, using mouse models (9). Here we determined that Cul3Δ403-459 has an altered 334 
structure that decreases interaction with the CSN. Yet the results also discern a novel, secondary, ligase-335 
independent autophagocytic KLHL3 degradation pathway that appears essential for the autosomal dominant 336 
phenotype. 337 
The current results confirm our prior work (14), indicating that that Cul3Δ403-459 is hyperneddylated, 338 
when expressed in cells. Ibeawuchi and colleagues (10), in contrast, could not detect hyperneddylation of 339 
Cul3Δ403-459 and suggested that the mutant protein is neddylated less efficiently than WT. A potential 340 
resolution to this paradox is apparent from the work of Schumacher and colleagues (24), who also documented 341 
that Cul3Δ403-459 is hyperneddylated in cells, but found that the neddylation process itself was less efficient. 342 
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They demonstrated that the defect lies in a failure of the CSN to associate with Cul3, and therefore, a failure of 343 
deneddylation. The current work confirms that Cul3Δ403-459 does not associate normally with the CSN (in this 344 
case, the catalytically-active JAB1 subunit), but this effect is not because the deleted amino acid sequence 345 
actually binds to JAB1. FHHt-causing Cul3 mutations lead to deletion of exon 9, which encodes the 4HB 346 
domain (Figure 1A). Min et al. (15) examined the CSN binding domain of a homologous cullin, cullin 1, and 347 
suggested that it lies within the 4HB domain. To determine whether the same domain is relevant in Cul3 348 
binding to CSN, we mapped the Cul3 domains that are required for association with JAB1. Using multiple Cul3 349 
constructs, we determined that the 4HB domain is neither necessary nor sufficient for CSN binding. Instead, the 350 
α/β1 domain, which lies adjacent to the 4HB domain, was identified as essential for association with the CSN. 351 
Since the α/β1 domain is not directly altered by the Cul3Δ403-459 mutation, the results suggest that the 352 
mutation disrupts binding to the CSN through alterations in the protein folding of Cul3; this suggestion aligns 353 
with the structural modeling data of Schumacher and colleagues (24). 354 
Since Cul3Δ403-459 does not bind efficiently to JAB1 protein we tested whether JAB1 knockdown 355 
could mimic the effects of Cul3Δ403-459 in cultured cells. Knockdown of JAB1 with siRNA decreased, rather 356 
than increased, WNK4 protein abundance indicating increased CRL activity (Figure 2). This suggests that JAB1 357 
knockdown alone cannot mimic Cul3Δ403-459 effects on WNK4; it should be noted, however, that CRL 358 
activity can differ between cell culture models and in vivo. The CSN positively regulates CRLs in vivo (22), 359 
whereas in vitro CRLs are negatively regulated by the CSN (36). Further, in vivo, experiments are needed to 360 
fully understand the effects of JAB1 inhibition.  361 
The Cul3Δ403-459 K712R mutant prevented NEDD8 conjugation, effectively inhibiting ubiquitin ligase 362 
activity. However, Cul3Δ403-459 K712R, unexpectedly, still showed significant degradation of KLHL3 (Figure 363 
4D), suggesting that degradation might be due to a non-ligase effect of the mutant Cul3Δ403-459. The results 364 
suggest that this ligase-independent degradation of KLHL3 occurs through the autophagy pathway, as two 365 
different inhibitors of this pathway, chloroquine, and 3-MA, both prevented KLHL3 degradation. Thus, as the 366 
schematic depicts in Figure 10, Cul3Δ403-459 facilitates KLHL3 degradation through two different pathways. 367 
KLHL3 is ubiquitylated and degraded via the proteasome. Additionally, KLHL3 can be degraded via selective 368 
autophagy, which is stimulated by the Cul3 mutant in a ligase-independent manner. Furthermore, the results 369 
here suggest that degradation of KLHL3 contributes importantly to WNK4 accumulation in FHHt. As shown, in 370 
the absence of WT-Cul3 (in HEK293T
Cul3-KO
 cells), Cul3Δ403-459 cannot degrade WNK4, even when KLHL3 371 
is abundant (Figure 7A). In cells that simultaneously express WT-Cul3 with Cul3Δ403-459, however, KLHL3 372 
abundance proves limiting for WNK4 degradation (Figure 7B), and thus it is the ability of the mutant Cul3 to 373 
drive KLHL3 degradation that proves essential. These observations provide substantial insight into the 374 
mechanisms of the disease, which is characterized by the presence of one WT and one mutant Cul3 allele. In 375 
this case, the protein generated from Cul3Δ403-459 cannot degrade WNK4, creating functional 376 
haploinsufficiency, as suggested. Yet the ability of the WT-Cul3 protein to facilitate WNK kinase degradation 377 
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is limited by the low abundance of KLHL3; this is maintained by enhanced proteasomal- and autophagy-driven 378 
KLHL3 degradation (Figure 10).  379 
The Cul3 mutation is contained within a protein that is a part the UPS, yet Cul3Δ403-459 causes an 380 
increase in autophagic degradation of KLHL3 (Figure 6B). The reason for this could be due to the relationship 381 
between the two degradative pathways. The UPS and autophagy were once thought to be separate mechanisms 382 
for regulated protein turnover, however, recent work has demonstrated that the two pathways may not be 383 
independent of one another. First, inhibition of the proteasome causes an increase in autophagy (8). This is most 384 
likely due to the fact that many proteins involved in the autophagy pathway are substrates for E3 ubiquitin 385 
ligases, including CRLs, and are negatively regulated via the UPS (7). Additionally, ubiquitylated proteins can 386 
be shuttled to the autophagophore (the vesicle that ultimately binds to the lysosome) via a linker protein, such as 387 
p62 (11). These proteins connect the two pathways by binding to both ubiquitylated proteins and 388 
autophagophore-membrane proteins allowing for ubiquitylated proteins to be degraded via autophagy. p62 389 
binds to KLHL3 and mediates its degradation via autophagy when the proteasomal pathway is inhibited (16). 390 
Thus, the Cul3 mutation could lead to upregulation of p62-mediated autophagic degradation of KLHL3; 391 
moreover, the impairment of CRL substrate degradation, as shown with the Cul3 mutant, could cause activation 392 
of autophagy due to accumulation of CRL substrates that are critical for the process. 393 
CRLs can associate with hundreds of substrate adaptors which can target thousands of substrates. Global 394 
deletion of the Cul3 gene is embryonic lethal in mice (26). So, the fact that Cul3Δ403-459 doesn’t produce 395 
widespread phenotypic effects has been perplexing. Here, we suggest that this paradox is resolved by dual 396 
effects of the Cul3Δ403-459 mutant protein, loss of function with respect to WNK4 degradation, and gain of 397 
function with respect to autophagocytic degradation of KLHL3. The latter effect likely contributes to the 398 
apparent tissue specificity for the disease to disrupt kidney and vascular smooth muscle. Although Cul3Δ403-399 
459 avidly binds to and degrades KLHL3, its effects on other adaptor proteins are different. The substrate 400 
adaptors Bacurd1 and RhoBTB1 similarly showed higher levels of interaction with Cul3Δ403-459 compared to 401 
WT-Cul3 (10). Yet, Cul3Δ403-459 degraded RhoBTB1 less efficiently compared to WT-Cul3, and Bacurd1 402 
showed no change in abundance. Here, Keap1, also known as Kelch-like 19, like Bacurd1, did not show a 403 
change in protein abundance due to Cul3Δ403-459 (Figure 9). Although Cul3Δ403-459 has differential effects 404 
on these substrate adaptors, the effects of Cul3Δ403-459 on their respective substrates were similar. Analogous 405 
to WNK4, the Bacurd1 substrate RhoA, which is expressed in the vascular smooth muscle and important for 406 
arterial pressure regulation, was upregulated by Cul3Δ403-459 (1). Additionally, as shown above, the Keap1 407 
substrate and oxidative stress response protein, Nrf2, showed increased protein abundance (Figure 9). On the 408 
other hand, cyclin E, a protein involved in cell cycle regulation and a substrate of Cul3, was unaffected by 409 
Cul3Δ403-459. The data demonstrate that the altered structure of Cul3Δ403-459 may be sequestering adaptors 410 
in a manner that prevents normal ubiquitin ligase activity toward the substrate; yet KLHL3 may be one of only 411 
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a few adaptors that undergoes active degradation, providing specificity for tissues and cell types in which this 412 
protein is highly expressed. 413 
All FHHt patients reported to date who harbor mutations in Cul3 are heterozygous (4). Some have 414 
suggested that the Cul3Δ403-459 protein is unstable, leading to functional haploinsufficiency of the wild type 415 
protein; according to this model, individuals with one functional Cul3 allele should exhibit the phenotype (1, 416 
24). Yet, Uchida and colleagues generated a mouse model that lacked one Cul3 allele, expressing approximately 417 
half as much Cul3 protein as control mice; the mice, however, did not show any evidence of the FHHt 418 
phenotype (2). Further, Ferdaus and colleagues (9) recently showed that mice with one Cul3 allele also lack 419 
features of FHHt, whereas mice with one mutant and one wild type allele exhibit frank hyperkalemic 420 
hypertension. While the protein derived from Cul3Δ403-459 does appear to be unstable, in vivo (1, 24), the 421 
current results suggest that the FHHt phenotype requires a second, dominant-negative effect. In support of this, 422 
we found clear evidence for a dominant effect of Cul3Δ403-459 on Cul3 WT, when the ratio of WT to mutant 423 
construct was varied (Figure 8). This is largely consistent with the model suggested by Sigmund and colleagues, 424 
who found that Cul3Δ403-459 exhibited enhanced interaction with substrate adaptors, such as KLHL3, and 425 
suggested that the mutant cullin might act in a dominant manner, despite reduced abundance, by sequestering 426 
adaptor proteins (10). 427 
The results here show only a modest change in WNK4 when WT Cul3 and Cul3Δ403-459 are 428 
transfected together, and increasing the ratio of WT Cul3 to Cul3Δ403-459 further diminished the effects on 429 
WNK4 abundance. This raises questions about the direct relevance of this to the human disease, as all FHHt 430 
patients are heterozygous, with one WT and one mutant allele. Additionally, in experimental disease models, 431 
the abundance of Cul3Δ403-459 is very low, relative to the wild type allele. Yet, Ferdaus and colleagues (9) 432 
showed recently that Cul3Δ403-459 exerts dominant effects, in vivo, despite its low abundance. Thus, these 433 
limitations of using HEK293 cells imply that these hypotheses should be explored using physiologically more 434 
relevant model systems. 435 
Thus, the current results clarify the consequences of deletion of exon 9 in Cul3, and provide novel 436 
information about how Cul3 interacts with the CSN. They suggest that this interaction requires the α/β1 domain, 437 
which lies next to, but is distinct from, the 4HB domain deleted in the human disease. Thus, although the 438 
deletion impairs binding of Cul3 to the CSN, the deleted region itself does not mediate the association. 439 
Furthermore, the results stress the importance of KLHL3 in the regulation of WNK4. Our data would be 440 
consistent with an effect of the mutant Cul3 protein to bind avidly to specific substrate adaptors, forming 441 
unstable and ineffective complexes. Additional studies will be required to further evaluate this hypothesis. 442 
 443 
 444 
 445 
  446 
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Figure Legends 584 
Figure 1. CSN binds to Cul3 at the α/β1 domain. A) Diagram of Cul3 domain structure and schematic of the 585 
Cul3 constructs. B) Co-immunoprecipitation was performed with HEK293 cells transfected with myc-586 
JAB1 and FLAG-tagged WT-Cul3 or Cul3Δ403-459 and analyzed by immunoblot. Cul3Δ403-459 587 
exhibited a decreased interaction with JAB1 compared to WT-Cul3. C) The effects of Cul3Δ403-459 on 588 
JAB1 binding was determined by co-immunoprecipitation with N-terminal domain Cul3 constructs 589 
using anti-FLAG and analyzed by immunoblot. Co-immunoprecipitation of N-terminal domain Cul3 590 
constructs with (1-459) and without (1-402) the 4HB domain showed no binding to JAB1. D) Segments 591 
of the Cul3 protein were generated with a GST tag and co-transfected with myc-tagged JAB1. Co-592 
immunoprecipitation was performed using glutathione sepharose beads. Immunoblotting for JAB1 593 
showed binding to 4HB:α/β1 and α/β1 Cul3 constructs, but not to 4HB, WH-A:α/β:WH-B, or R1:R2:R3 594 
Cul3 constructs. E) Co-immunoprecipitation was performed with myc-JAB1 and FLAG-tagged WT-595 
Cul3 or Cul3Δ461-586 constructs. Cul3Δ461-586 demonstrated less binding to JAB1 protein compared 596 
to WT-Cul3. Immunoblotting for NEDD8 showed enhanced neddylation of the Cul3Δ461-586 construct 597 
compared to WT-Cul3. The asterisk indicates a nonspecific band. 598 
Figure 2. Effects of JAB1 inhibition on Cul3 neddylation and substrate protein abundance. Myc-tagged 599 
KLHL3 or WNK4 was co-transfected into HEK293 cells with either JAB1 siRNA or control siRNA. 600 
The proteins were examined by immunoblot in cells with endogenous WT-Cul3. JAB1 siRNA decreased 601 
JAB1, KLHL3, and WNK4 abundance, increased NEDD8 abundance, and the neddylated form of Cul3 602 
(top band). β-actin was used as a loading control.  603 
Figure 3. Cul3Δ403-459 decreases the stability of KLHL3. A. Cycloheximide chase assay was performed 604 
with HEK293 cells co-transfected with myc-tagged KLHL3 and either FLAG-WT Cul3 or FLAG-605 
Cul3Δ403-459. Due to a robust decrease in KLHL3 by the Cul3Δ403-459 which prevented 606 
quantification, the amount of Cul3Δ403-459 transfected was reduced to half of WT Cul3. 607 
Cycloheximide (100 µg/ml) was added 36 h post transfection and cells were lysed at 0, 1, 2, 4, 8, and 24 608 
h time points. KLHL3 protein abundance was more rapidly degraded in cells co-expressing Cul3Δ403-609 
459. Right, quantitative analysis of KLHL3 protein abundance. Stain-free imaging was used as a loading 610 
control. Linear regression was used to determine the slope of each group. The differences between the 611 
slopes were significantly different (P < 0.001). Data represent mean values ± SEM relative to the 0 h 612 
time point. Statistical differences were examined using two-tailed unpaired Student’s t test. * P = 0.01 613 
vs WT. B. Cycloheximide chase assay was performed with HEK293 cells co-transfected with myc-614 
tagged WNK4 in the presence or absence of KLHL3. Cycloheximide (100 µg/ml) was added 36 h post 615 
transfection and cells were lysed at 0, 2, 4, and 6 h time points. Stain-free imaging was used as a loading 616 
control. C. Left, quantitative analysis of KLHL3; all data points are relative to WT Cul3 0 h time point. 617 
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Right, quantitative analysis of WNK4 protein abundance; all data points are relative to WNK4 without 618 
KLHL3 0 h time point. The effects of Cul3Δ403-459 on KLHL3 abundance is similar to the effects of 619 
KLHL3 on WNK4 abundance. 620 
Figure 4. Ligase-deficient Cul3Δ403-459 K712R double mutant blunts the effects of Cul3Δ403-459 on 621 
KLHL3 and WNK4. A) FLAG-tagged Cul3 constructs were co-transfected into HEK293 cells and 622 
immunoprecipitated using FLAG antibody. Immunoblotting for NEDD8 showed no neddylation of the 623 
K712R mutant for both WT-Cul3 and Cul3Δ403-459. B) Co-immunoprecipitation was performed with 624 
HEK293 cells transfected with myc-KLHL3 and FLAG-tagged WT-Cul3, Cul3Δ403-459, Cul3Δ403-625 
459 K712R, or empty vector. Pull-down with FLAG antibodies showed that KLHL3 had more binding 626 
to Cul3Δ403-459 and Cul3Δ403-459 K712R proteins. C) A ubiquitin assay was performed for KLHL3 627 
by co-transfecting FLAG-tagged Cul3 constructs with myc-KLHL3 and HA-tagged ubiquitin. 628 
Immunoprecipitation was performed using anti-myc antibody and poly-ubiquitylation of KLHL3 was 629 
visualized by immunoblotting for anti-HA. Cul3Δ403-459 K712R double mutant attenuated the higher 630 
abundance of KLHL3 ubiquitylation shown with Cul3Δ403-459. D) Top, abundance of myc-tagged 631 
KLHL3 and WNK4 protein was examined by immunoblot in HEK293T
Cul3-KO
 cells co-transfected with 632 
different FLAG-tagged Cul3 constructs. KLHL3 and WNK4 expression was higher and lower, 633 
respectively, in Cul3Δ403-459 K712R compared to Cul3Δ403-459. Bottom, quantitative analysis of 634 
KLHL3 and WNK4 protein abundance. Stain-free imaging was used as a loading control. Data represent 635 
individual values as well as mean ± SEM relative to control. Statistical differences were examined by 636 
one-way ANOVA with Tukey’s post hoc analysis.  637 
Figure 5. Effects of proteasome inhibition on Cul3Δ403-459-mediated KLHL3 degradation. The pathway 638 
for degradation of KLHL3 by the Cul3Δ403-459 mutant was examined by inhibiting the proteasomal 639 
pathway with the drug MG132. HEK293 cells were co-transfected with myc-KLHL3 and either no Cul3 640 
or FLAG-Cul3Δ403-459. The cells were incubated with vehicle or 10 M MG132 for 18 hours before 641 
harvesting. Immunoblot analysis showed that inhibition of the proteasomal pathway partially blocked 642 
Cul3Δ403-459-mediated KLHL3 degradation. Right, quantitative analysis of KLHL3 protein 643 
abundance. GAPDH was used as a loading control. Data represent individual values as well as mean ± 644 
SEM relative to control. Statistical differences were examined by one-way ANOVA with Tukey’s post 645 
hoc analysis.  646 
Figure 6. Effects of autophagy inhibition on Cul3Δ403-459-mediated KLHL3 degradation. The pathway 647 
for degradation of KLHL3 by the Cul3Δ403-459 mutant was examined by inhibiting the autophagy 648 
pathway with the drugs chloroquine or 3-methyladenine (3-MA). HEK293 cells were co-transfected 649 
with myc-KLHL3 and either no Cul3 or FLAG-Cul3Δ403-459. The cells were incubated with vehicle or 650 
100 M chloroquine (A), or 5 mM 3-MA (C) for 18 hours before harvesting. Immunoblot analysis 651 
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showed that inhibition of autophagy with chloroquine or 3-MA partially blocked Cul3Δ403-459-652 
mediated KLHL3 degradation, while administration of the drugs together completely eliminated KLHL3 653 
degradation. Right, quantitative analysis of KLHL3 protein abundance. B) Bar graph depicting the 654 
percent change in KLHL3 protein abundance caused by autophagy inhibition from chloroquine 655 
administration between control and Cul3Δ403-459 groups. D) Cells were incubated with both the 656 
proteasomal inhibitor MG132 and autophagy inhibitor chloroquine simultaneously. Administration of 657 
the drugs together completely eliminated KLHL3 degradation. GAPDH was used as a loading control. 658 
Data represent individual values as well as mean ± SEM relative to control. Statistical differences were 659 
examined by one-way ANOVA with Tukey’s post hoc analysis.  660 
Figure 7. Increased expression of KLHL3 can overcome effects of Cul3Δ403-459 on WNK4 in the 661 
presence of WT-Cul3. HEK293T
Cul3-KO
 cells (A) or HEK293 cells (B) were transfected with myc-662 
WNK4 and either FLAG-tagged WT-Cul3 or Cul3Δ403-459 along with increasing amounts of myc-663 
tagged KLHL3 and analyzed by immunoblot. The increased KLHL3 expression only slightly decreased 664 
WNK4 protein abundance in HEK293T
Cul3-KO
 cells, however, HEK293 cells had a larger decrease in 665 
WNK4 which was not significantly different from WT-Cul3. Bar graphs depict quantification of KLHL3 666 
and WNK4 protein abundance. Stain-free imaging was used as a loading control. Data represent relative 667 
individual values as well as mean ± SEM. Statistical differences were examined by one-way ANOVA 668 
with Tukey’s post hoc analysis. 669 
Figure 8. WT-Cul3 and Cul3Δ403-459 compete for KLHL3. Myc-tagged KLHL3 and WNK4 were co-670 
transfected with different amounts of FLAG-tagged WT-Cul3 and Cul3Δ403-459. The ratio of FLAG-671 
WT-Cul3 to Cul3Δ403-459 was adjusted as labeled and analyzed by immunoblot. β-actin was used as a 672 
loading control. Increasing the ratio of Cul3Δ403-459 to WT-Cul3 decreased KLHL3 and increased 673 
WNK4 protein expression. The opposite was observed when increasing the ratio of WT-Cul3 to 674 
Cul3Δ403-459. Bar graphs are a summary of the densitometry analysis of the blot. 675 
Figure 9. Effects of Cul3Δ403-459 on Keap1, Nrf2, and cyclin E. Top, abundance of endogenous Keap1, 676 
Nrf2, and cyclin E protein was examined in HEK293T
Cul3-KO
 cells co-transfected with different FLAG-677 
tagged Cul3 constructs and analyzed by immunoblot. Keap1 and cyclin E showed no difference in 678 
protein abundance between the groups. Nrf2 protein levels were higher in Cul3Δ403-459 and Cul3Δ403-679 
459 K712R transfected cells. Stain-free imaging was used as a loading control. Bottom, quantitative 680 
analysis of Keap1, Nrf2, and cyclin E protein abundance. Data represent relative individual values as 681 
well as mean ± SEM. Statistical differences were examined by one-way ANOVA with Tukey’s post hoc 682 
analysis. 683 
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Figure 10. Simplified model of Cul3Δ403-459 effects on KLHL3 and WNK4. KLHL3 is degraded by two 684 
separate pathways. Under normal conditions, the WT-Cul3-KLHL3 ubiquitin ligase complex (left) 685 
ubiquitylates WNK4 targeting it for degradation via the proteasome. Separate from cullin-RING-ligase 686 
activity, KLHL3 is also degraded through selective autophagy. The Cul3Δ403-459 FHHt mutant (right) 687 
targets KLHL3 instead of WNK4 for ubiquitylation; causing proteasomal degradation of KLHL3 while 688 
preventing WNK4 turnover. Additionally, expression of the Cul3 mutant causes enhanced autophagic-689 
mediated degradation of KLHL3. The lower levels of KLHL3 through both proteasomal and autophagic 690 
degradation prevent WT-Cul3 from interacting with WNK4, leading to an increase in WNK4 protein 691 
abundance. 692 
 693 
 694 
 695 
  696 
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Table 1. Antibodies used for Western blot 697 
Figure Target Antibody Name Source 1° Dilution  2° Dilution  
1E,2 JAB1 JAB1 FL-334 Santa Cruz, SC-9074 1:1,000, 1h at RT 1:5,000 
1C,1D JAB1 JAB1 6C3.38 Thermo Scientific 1:2,000, 1h at RT 1:5,000 
1D GST GST B-14 Santa Cruz, SC-138 1:1,000, 1h at RT 1:2,500 
1,2,3,4,5,6,7,8 Myc c-Myc Sigma Aldrich, M5546 1:5,000, 1h at RT 1:10,000 
1E,2,4A NEDD8 NEDD8 19E3 Cell Signaling 2754 1:1,000, o/n at 4°C 1:2,500 
2,4D Cul3 Cul3 Cell Signaling 2759 1:1,000, o/n at 4°C 1:2,500 
2,8 β-actin β-actin Abcam Ab8227 1:5,000, 1h at RT 1:2,500 
1,4,5,6,7,8,9 FLAG FLAG M2 Sigma Aldrich, F3165 1:10,000, 1h at RT 1:10,000 
4C HA HA.11 Covance MMS-101P 1:1,000, 1h at RT 1:10,000 
5,6 GAPDH GAPDH Santa Cruz, SC-20357 1:1,000, 1h at RT 1:2,500 
9 Keap1 Keap1 Abcam Ab139729 1:1,000, o/n at 4°C 1:2,500 
9 Nrf2 Nrf2 H-300 Santa Cruz, SC-13032 1:1,000, o/n at 4°C 1:2,500 
9 Cyclin E Cyclin E HE12 Santa Cruz, SC-247 1:1,000, o/n at 4°C 1:2,500 
 698 
Abbreviations: App, application; RT, room temperature; o/n, overnight; JAB1, jun activation domain-binding protein-1; GST, glutathione S-699 
transferase; NEDD8, neuronal precursor cell expressed developmentally down-regulated protein 8; Cul3, cullin 3; Keap1, kelch-like ECH-associated 700 
protein 1; Nrf2, nuclear factor erythroid 2-related factor 2. 701 
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